Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Canada)

Index « Auteurs » - entrée « M. Marty »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
M. Martuzzi < M. Marty < M. Maruši  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
001927 (2006) A. T. Farrell [États-Unis] ; I. Papadouli [Royaume-Uni] ; A. Hori [Japon] ; M. Harczy [Canada] ; B. Harrison [Australie] ; W. Asakura [Japon] ; M. Marty [France] ; R. Dagher [États-Unis] ; R. Pazdur [États-Unis]The advisory process for anticancer drug regulation: a global perspective

List of associated KwdEn.i

Nombre de
documents
Descripteur
1Additional experts
1Adec
1Adverse drug reactions
1Advisor
1Advisory boards
1Advisory committee
1Advisory committees
1Advisory group
1Advisory process
1American society
1Answer questions
1Antineoplastic agent
1Antineoplastic drugs
1Associate members
1Australian drug evaluation committee
1Cancerology
1Case basis
1Centralized procedure
1Clearance process
1Clinical oncology meeting
1Clinical trial consultation
1Clinical trials
1Clinical trials package
1Committee members
1Common theme
1Consumer representative
1Core group
1Core member
1Core members
1Core panel
1Deliberation
1Different regions region
1Drug
1Drug administration
1Drug applications
1Drug development phase
1Drug evaluation
1Drug oncology products
1Drug regulation
1Emea
1European medicines agency
1Evaluator
1Executive committee
1Expert advice
1Expertise
1External advisors
1External consultants
1External evaluators
1External experts
1Global perspective
1Goods administration
1Guideline
1Health canada
1Health website
1High level
1Independent advice
1Individual consultants
1Individual countries
1Individual experts
1Individual members
1Industry representative
1Internal assessors
1Japanese pharmaceuticals
1June
1Malignant tumor
1Marketing applications
1Marketing authorization
1Medical devices
1Medical devices agency
1Medical oncology
1Medicinal products
1Nancial interest
1Odac
1Odac meeting
1Odac members
1Oncologic drugs
1Oncology
1Oncology drug
1Oncology drug development
1Oncology drug products
1Oncology drugs
1Oncology products
1Oncology therapies
1Other regions
1Particular evaluation
1Patient advocacy groups
1Patient consultants
1Patient groups
1Patient representation
1Patient representative
1Pharmaceutical
1Pharmaceutical industry
1Pharmaceutical sponsor
1Pmda
1Possible outcomes
1Prescription medicines
1Presubmission meetings
1Primary responsibility
1Proprietary information
1Regulatory

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "M. Marty" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i  \
                -Sk "M. Marty" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Canada
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    M. Marty
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024